A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments with Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
CompletedCTIS2023-508381-16-00
Transcend Therapeutics Inc.Post-Traumatic Stress Disorder
Start: 2024-06-13End: 2025-08-12Target: 20Updated: 2024-12-16